Home

  • Order to parcel locker

    Order to parcel locker

  • easy pay

    easy pay
  • Reduced price
Anticancer Agents

Anticancer Agents

Frontiers in Cancer Chemotherapy

9780841237452
1,323.00 zł
1,256.85 zł Save 66.15 zł Tax included
Lowest price within 30 days before promotion: 1,256.85 zł
Quantity
Product unavailable
Out of print

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
Describes cutting edge approaches in the development of anticancer agents for chemotherapy. These new and interdisciplinary approaches are aimed at the development of tumor specific anticancer agents while increasing the potency against drug-resistant tumors. The volume includes an overview of new paradigms for cancer drug discovery and development by NCI, new generation cytotoxic agents, mechanism based enzyme inhibitors as anticancer agents, anti-angiogenesis agents, antitumorvaccins, and tumor activated prodrugs using immunoconjugates of monoclonal antibodies with cytotoxic agents.
Product Details
OUP USA
82878
9780841237452
9780841237452

Data sheet

Publication date
2002
Issue number
1
Cover
hard cover
Pages count
380
Dimensions (mm)
157 x 236
Weight (g)
631
  • Preface; Cancer Drug Discovery and Development:: New Paradigms for a New Millennium; Evolutionary Biosynthesis of Anticancer Drugs; Some Recent Developments in the Synthesis and SAR of Novel Taxanes; New Generation Taxoids and Hybrids of Microtube-Stabilizing Anticancer Agents; Discodermolide and Taxol:: A Synergistic Drug Combination in Human Carcinoma Cell Lines; Highly Efficient Semisynthesis of Biologically Active Epothilone Derivatives; Synthetic and Semisynthetic Analogs of Epothilones:: Chemistry and Biological Activity; Synthesis and Biological Activity of Epothilones; Epothelones and Sarcodictyins:: From Combinatorial to Designed Analogs; Synthesis and Structure-Activity Relationship Studies of Cryptophycins:: A Novel Class of Potent Antimitotic Tumor Depsipeptides; Farnesyltransferase Inhibitors as Potential Anticancer Agents; Farnesyltransferase Inhibitors:: From Squalene Synthase Inhibitors to the Clinical Agent BMS-214662; Inhibiting Farnesyl Protein Transferase with Sch-66336:: Potentially a Selective Non-Cytotoxic herapy for Human Cancer; Pyrrolo[2,3-d]pyrimidine and Pyrazolo[3,4-d]pyrimidine Derivatives as Selective Inhibitors of the EGF Receptor Tyrosine Kinase; STI571:: A New Treatment Modality for CML; The Discovery and Development of Second-Generation Matrix Metalloproteinase Inhibitors for the Treatment of Cancer; Prospects for Anti-Angiogenic Therapies Based upon VEGF Inhibition; Carbohydrate-Based Tumor Antigens as Anti-Tumor Vaccine Agents; Drugs to Enhance the Therapeutic Potency of Anti-Cancer Antibodies; Author Index;
Comments (0)

  • Frequently purchased together

    No products available